Proteome Sciences Statistics
Total Valuation
PMSNF has a market cap or net worth of 8.38 million. The enterprise value is 28.99 million.
| Market Cap | 8.38M |
| Enterprise Value | 28.99M |
Important Dates
The next estimated earnings date is Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 295.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -3.71% |
| Owned by Insiders (%) | 11.72% |
| Owned by Institutions (%) | 40.80% |
| Float | 223.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.35 |
| PB Ratio | -0.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.35 |
| EV / Sales | 4.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.28 |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.08 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -10.39 |
| Interest Coverage | -2.51 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.93% |
| Return on Invested Capital (ROIC) | -34.66% |
| Return on Capital Employed (ROCE) | 31.14% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | 172,284 |
| Profits Per Employee | -126,844 |
| Employee Count | 36 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 5.92 |
Taxes
In the past 12 months, PMSNF has paid 220,578 in taxes.
| Income Tax | 220,578 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.29% in the last 52 weeks. The beta is 0.24, so PMSNF's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +125.29% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.13 |
| Relative Strength Index (RSI) | 49.21 |
| Average Volume (20 Days) | 14,615 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PMSNF had revenue of 6.20 million and -4.57 million in losses. Loss per share was -0.02.
| Revenue | 6.20M |
| Gross Profit | 1.08M |
| Operating Income | -3.11M |
| Pretax Income | -4.35M |
| Net Income | -4.57M |
| EBITDA | -2.93M |
| EBIT | -3.11M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 360,323 in cash and 21.09 million in debt, with a net cash position of -20.73 million.
| Cash & Cash Equivalents | 360,323 |
| Total Debt | 21.09M |
| Net Cash | -20.73M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -11.76M |
| Book Value Per Share | -0.04 |
| Working Capital | -19.08M |
Cash Flow
In the last 12 months, operating cash flow was -1.66 million and capital expenditures -374,024, giving a free cash flow of -2.03 million.
| Operating Cash Flow | -1.66M |
| Capital Expenditures | -374,024 |
| Free Cash Flow | -2.03M |
| FCF Per Share | n/a |
Margins
Gross margin is 17.43%, with operating and profit margins of -50.12% and -73.62%.
| Gross Margin | 17.43% |
| Operating Margin | -50.12% |
| Pretax Margin | -70.07% |
| Profit Margin | -73.62% |
| EBITDA Margin | -47.16% |
| EBIT Margin | -50.12% |
| FCF Margin | n/a |
Dividends & Yields
PMSNF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -54.46% |
| FCF Yield | -24.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PMSNF has an Altman Z-Score of -15.17 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.17 |
| Piotroski F-Score | 3 |